EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Outcomes from the International Society of Nephrology Hemolytic Uremic Syndromes International Forum

David Kavanagh, Gianluigi Ardissino, Vicky Brocklebank, Romy N Bouwmeester, Arvind Bagga, Rob Ter Heine, Sally Johnson, Christoph Licht, Alison L T Ma, Marina Noris, Manuel Praga, Eric Rondeau und 9 weitere

Kidney International · 2024

DOI: 10.1016/j.kint.2024.09.012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney International, 2024. Verfasst von David Kavanagh und 20 weiteren Autor:innen. Beteiligte Einrichtung: National Renal Complement Therapeutics Centre, Newcastle upon Tyne Hospitals National Health Service Foundation Trust, Newcastle upon Tyne, United Ki…. Hauptthemen laut MEDLINE: Nephrology, Hemolytic-Uremic Syndrome. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hemolytic uremic syndromes (HUSs) are a heterogeneous group of conditions, only some of which are mediated by complement (complement-mediated HUS). We report the outcome of the 2023 International Society of Nephrology HUS International Forum where a global panel of experts considered the current state of the art, identified areas of uncertainty, and proposed optimal solutions. Areas of uncertainty and areas for future research included the nomenclature of HUS, novel complement testing strategies, identification of biomarkers, genetic predisposition to atypical HUS, optimal dosing and withdrawal strategies for C5 inhibitors, treatment of kidney transplant recipients, disparity of access to treatment, and the next generation of complement inhibitors in complement-mediated HUS. The current rationale for optimal patient management is described.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NephrologyHemolytic-Uremic SyndromeHumansKidney TransplantationComplement System ProteinsComplement Inactivating AgentsBiomarkersSocieties, MedicalAtypical Hemolytic Uremic Syndrome

Stichwörter der Autor:innen

C5acute kidney injurycomplementhemolytic uremic syndromethrombotic microangiopathy

Substanzen

Complement System ProteinsComplement Inactivating AgentsBiomarkers

Autor:innen und Institutionen

  • National Renal Complement Therapeutics Centre, Newcastle upon Tyne Hospitals National Health Service Foundation Trust, Newcastle upon Tyne, United Kingdom; Complement Therapeutics Research Group, Translational and Clini…
  • Center for Hemolytic Uremic Syndrome (HUS) Prevention, Pediatric Nephrology, Dialysis and Transplantation Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda, Ospedale Maggiore Policl…
  • Radboud University Medical Center, Amalia Children's Hospital, Radboud Institute for Molecular Life Sciences, Department of Pediatric Nephrology, Nijmegen, The Netherlands.
  • Division of Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
  • Department of Pharmacy, Radboud University Medical Center, Nijmegen, The Netherlands.
  • National Renal Complement Therapeutics Centre, Newcastle upon Tyne Hospitals National Health Service Foundation Trust, Newcastle upon Tyne, United Kingdom; Great North Children's Hospital, Sir James Spence Institute, Ro…

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Kavanagh, D., Ardissino, G., Brocklebank, V., Bouwmeester, R. N., Bagga, A., Ter Heine, R., Johnson, S., Licht, C., Ma, A. L. T., Noris, M., Praga, M., Rondeau, E., Sinha, A., Smith, R. J. H., Sheerin, N. S., Trimarchi, H., Wetzels, J. F. M., Vivarelli, M., Van de Kar, N. C. A. J., …, & Forum Participants (2024). Outcomes from the International Society of Nephrology Hemolytic Uremic Syndromes International Forum. Kidney International. https://doi.org/10.1016/j.kint.2024.09.012

Vancouver

Kavanagh D, Ardissino G, Brocklebank V, Bouwmeester RN, Bagga A, Ter Heine R, et al. Outcomes from the International Society of Nephrology Hemolytic Uremic Syndromes International Forum. Kidney International. 2024. doi:10.1016/j.kint.2024.09.012

BibTeX
@article{Kavanagh2024,
  author = {Kavanagh, David and Ardissino, Gianluigi and Brocklebank, Vicky and Bouwmeester, Romy N and Bagga, Arvind and Ter Heine, Rob and Johnson, Sally and Licht, Christoph and Ma, Alison L T and Noris, Marina and Praga, Manuel and Rondeau, Eric and Sinha, Aditi and Smith, Richard J H and Sheerin, Neil S and Trimarchi, H and Wetzels, Jack F M and Vivarelli, Marina and Van de Kar, Nicole C A J and Greenbaum, Larry A and Forum Participants, Forum Participants},
  title = {Outcomes from the International Society of Nephrology Hemolytic Uremic Syndromes International Forum},
  journal = {Kidney International},
  year = {2024},
  doi = {10.1016/j.kint.2024.09.012}
}
Kostenlos starten →